Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: a Multi - Omics Perspective
Not yet recruitingOBSERVATIONAL
Enrollment
120
Participants
Timeline
Start Date
March 10, 2025
Primary Completion Date
March 9, 2026
Study Completion Date
February 9, 2028
Conditions
NSCLC Stage IIIA/BNSCLC Stage II
All Listed Sponsors
lead
Ziming Li
OTHER
NCT06856798 - Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: a Multi - Omics Perspective | Biotech Hunter | Biotech Hunter